Teleflex (TFX)

• Market cap: $6.32B
• 1 day: 0.56%
• 5 days: 0.21%
• 1 month: -18.69%
• 3 months: -24.35%
• 6 months: -44.61%
• Year to date: -23.89%
• 1 year: -38.66%
• 5 years: -57.20%
• 10 years: 14.60%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Employees: 14,100

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

74% more call options, than puts

Call options by funds: $4.11M | Put options by funds: $2.37M

4.36% more ownership

Funds ownership: 94.79% [Q3] → 99.15% (+4.36%) [Q4]

7% less first-time investments, than exits

New positions opened: 85 | Existing positions closed: 91

3% less funds holding

Funds holding: 521 [Q3] → 504 (-17) [Q4]

10% less repeat investments, than reductions

Existing positions increased: 169 | Existing positions reduced: 188

26% less capital invested

Capital invested by funds: $11B [Q3] → $8.19B (-$2.85B) [Q4]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $140 3% upside
• Avg. target: $153 12% upside
• High target: $191 40% upside

5 analyst ratings

• positive: 1 20%
• neutral: 3 60%
• negative: 1 20%

Morgan Stanley Patrick Wood 46% 1-year accuracy 6 / 13 met price target	40% upside $191	Overweight Maintained	5 Mar 2025
B of A Securities Craig Bijou 56% 1-year accuracy 5 / 9 met price target	3% upside $140	Underperform Downgraded	4 Mar 2025
Truist Securities Richard Newitter 50% 1-year accuracy 22 / 44 met price target	9% upside $149	Hold Maintained	3 Mar 2025
Wells Fargo Larry Biegelsen 30% 1-year accuracy 14 / 46 met price target	7% upside $146	Equal-Weight Maintained	28 Feb 2025
Piper Sandler Matt O'Brien 35% 1-year accuracy 19 / 54 met price target	3% upside $140	Neutral Downgraded	28 Feb 2025